Matthew Julian Meyer is a Chief Business Officer, Life Sciences at Wilson Sonsini Goodrich & Rosati. He possess expertise in pharmaceutical industry, strategy, commercialization, licensing, life sciences and 22 more skills. Colleagues describe him as "Matt provided mission-critical business advice to support the successful licensing of critical IP from Stanford and initial venture financing of Foresight Diagnostics. From his unique position leading WSGR’s life science business advisory practice, Matt provided creative strategic insights and practical operational input on our business plan, investor pitch deck and a range of other company-critical matters from board composition to product reimbursement and market access strategy. Throughout, he was consistently responsive, thoughtful and a pleasure to work with. I look forward to the opportunity to work with Matt again." and "I have known and worked with Matt for 20 years. He’s extremely smart, a quick study, capable, and a hardworking executive who has been able to achieve success for investors in difficult situations. He has a clear understanding of what’s needed on both sides of a transaction and his deep integrity is able to bring disparate parties together to effect successful outcomes. Matt has a unique combination of commercial, transactional and operational experience developed in a range of large and emerging growth biotech and diagnostics companies that enable him to have quick and valuable impact on a business. Any company would be lucky to have Matt as either a member of their management team or working on their behalf. "